vTv Therapeutics, Inc. (VTVT)
33.89
+0.64
(+1.91%)
USD |
NASDAQ |
Aug 24, 16:00
33.61
-0.28
(-0.83%)
After-Hours: 20:00
vTv Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.0051 |
| June 30, 2025 | 0.0286 |
| March 31, 2025 | 0.0158 |
| December 31, 2024 | 0.0139 |
| September 30, 2024 | 0.0142 |
| June 30, 2024 | 0.0155 |
| March 31, 2024 | 0.0143 |
| December 31, 2023 | -0.0214 |
| September 30, 2023 | -0.0337 |
| June 30, 2023 | -0.0165 |
| March 31, 2023 | -0.0237 |
| December 31, 2022 | -0.0667 |
| September 30, 2022 | -0.0874 |
| June 30, 2022 | -0.0688 |
| March 31, 2022 | -0.0781 |
| December 31, 2021 | -0.0957 |
| September 30, 2021 | -0.0628 |
| June 30, 2021 | -0.0158 |
| March 31, 2021 | -0.0141 |
| December 31, 2020 | -0.0114 |
| Date | Value |
|---|---|
| September 30, 2020 | -0.063 |
| June 30, 2020 | -0.0783 |
| March 31, 2020 | -0.0864 |
| December 31, 2019 | -0.1451 |
| September 30, 2019 | -0.1887 |
| June 30, 2019 | -0.2206 |
| March 31, 2019 | -0.2283 |
| December 31, 2018 | -0.1896 |
| September 30, 2018 | -0.414 |
| June 30, 2018 | -0.2667 |
| March 31, 2018 | -0.1335 |
| December 31, 2017 | -0.1297 |
| September 30, 2017 | -0.1417 |
| June 30, 2017 | -0.1789 |
| March 31, 2017 | -0.1519 |
| December 31, 2016 | -0.1216 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -0.0934 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Spyre Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 87.59M |
| Total Liabilities (Quarterly) | 8.961M |
| Shareholders Equity (Quarterly) | 78.63M |
| Current Ratio | 12.48 |
| Net Debt Paydown Yield | 0.02% |